Rite Aid Corporation, a prominent American drugstore chain, is contemplating shuttering 400 to 500 outlets amidst bankruptcy deliberations. While talks are ongoing, the company's massive $3.3 billion debt looms large. Concurrently, federal lawsuits and a DOJ action over alleged mishandling of opioid prescriptions challenge the pharmacy's operations.
Currently, Rite Aid is negotiating the terms of a bankruptcy plan, which may result in the permanent closure of its stores, now numbering more than 2,100 in the 17 U.S. states. It was reported that some individuals familiar with the ongoing talks with creditors told the Wall Street Journal that the company suggested closing up to 500 pharmacies in bankruptcy.
It was also said that Rite Aid also proposed to either sell or allow creditors to take over the remaining drug stores. As per Fox Business, there is one group of bondholders that prefers to liquidate a greater number of stores, and officials are said to be discussing the exact number.
But while there is an ongoing talk, Rite Aid said they have not yet made any decision. It was already reported that the drugstore chain is planning to file for bankruptcy protection due to the more than $3.3 billion debt it has incurred. It also faces thousands of federal lawsuits about its alleged part in the sweeping spread of opioids.
Washington Examiner reported that Rite Aid is also being confronted by huge pressure from the U.S. Department of Justice, which filed a lawsuit against the company for allegedly "knowingly" filling up unlawful prescriptions for controlled substances. The DOJ said the pharmacy giant missed "obvious red flags" that the medications it sold were being abused by customers such as medical fentanyl and oxycodone.
Rite Aid disagreed with how the government described its handling of opioid medications. It also denied the claims it is filling illegal prescriptions.
Photo by: Chance Pereira/Flickr(CC BY-SA 2.0)


Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Australia’s December Trade Surplus Expands but Falls Short of Expectations
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 



